Envestnet Asset Management Inc. Sells 51,738 Shares of Centene Corporation $CNC

Envestnet Asset Management Inc. trimmed its position in Centene Corporation (NYSE:CNC) by 6.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 707,685 shares of the company’s stock after selling 51,738 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.14% of Centene worth $25,250,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Hantz Financial Services Inc. raised its stake in Centene by 1,109.2% in the third quarter. Hantz Financial Services Inc. now owns 6,542 shares of the company’s stock valued at $233,000 after buying an additional 6,001 shares during the period. Peak Retirement Planning Inc. raised its stake in Centene by 181.6% in the 3rd quarter. Peak Retirement Planning Inc. now owns 72,201 shares of the company’s stock valued at $2,576,000 after acquiring an additional 46,562 shares during the period. AGF Management Ltd. lifted its holdings in Centene by 115.1% during the 3rd quarter. AGF Management Ltd. now owns 113,849 shares of the company’s stock valued at $4,062,000 after purchasing an additional 60,919 shares during the last quarter. Jones Financial Companies Lllp boosted its position in Centene by 222.7% during the third quarter. Jones Financial Companies Lllp now owns 28,441 shares of the company’s stock worth $991,000 after purchasing an additional 19,628 shares during the period. Finally, UMB Bank n.a. raised its position in shares of Centene by 49.5% in the third quarter. UMB Bank n.a. now owns 3,962 shares of the company’s stock valued at $141,000 after purchasing an additional 1,311 shares during the period. Institutional investors own 93.63% of the company’s stock.

Centene Stock Performance

CNC opened at $39.17 on Friday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.08 and a current ratio of 1.10. Centene Corporation has a 52-week low of $25.08 and a 52-week high of $66.03. The firm has a market cap of $19.25 billion, a P/E ratio of -2.88, a price-to-earnings-growth ratio of 0.90 and a beta of 0.48. The business’s fifty day moving average is $42.08 and its 200-day moving average is $36.20.

Centene (NYSE:CNC) last posted its quarterly earnings data on Friday, February 6th. The company reported ($1.19) earnings per share for the quarter, topping the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion during the quarter, compared to analysts’ expectations of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. Centene’s revenue was up 21.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.80 earnings per share. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Sell-side analysts expect that Centene Corporation will post 6.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the stock. Oppenheimer reiterated an “outperform” rating and issued a $45.00 price target on shares of Centene in a research note on Thursday, October 30th. Argus raised Centene to a “hold” rating in a research report on Monday. TD Cowen lifted their price target on Centene from $34.00 to $38.00 and gave the stock a “hold” rating in a report on Wednesday. Mizuho set a $47.00 price objective on Centene in a report on Friday, January 9th. Finally, Truist Financial boosted their target price on shares of Centene from $45.00 to $47.00 and gave the company a “buy” rating in a research report on Monday, January 5th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, Centene presently has an average rating of “Hold” and an average price target of $41.50.

Key Headlines Impacting Centene

Here are the key news stories impacting Centene this week:

• Positive Sentiment: Deutsche Bank raised its price target to $39, signaling some support for the stock from the Street. Deutsche Bank Boosts Price Target
• Positive Sentiment: Value-oriented writeups (Zacks and MSN) highlight Centene as a long‑term value pick, which can attract buy‑and‑hold investors looking past near‑term volatility. Zacks Value Stock Article
• Positive Sentiment: Ambetter Health (a Centene brand) completed a new community playground with KABOOM! and the City of Hialeah — a reputation/ESG positive that supports member/community goodwill but is unlikely to move near‑term earnings. Ambetter Playground PR
• Positive Sentiment: Superior HealthPlan and the Centene Foundation expanded the “No One Eats Alone” program in Texas schools — another CSR item that supports brand and member engagement. NOEA Initiative PR
• Neutral Sentiment: TD Cowen raised its price target to $38 but maintained a “hold,” a modestly constructive move that still signals limited upside in the near term. TD Cowen PT Raise
• Neutral Sentiment: Argus moved Centene to a “hold” and Cantor Fitzgerald reaffirmed “neutral” — multiple firms keeping conservative stances that limit buying pressure. Argus Hold / Zacks Reference
• Neutral Sentiment: Guggenheim issued a “hold” on Centene, reinforcing the Street’s broadly cautious stance. Guggenheim Hold
• Negative Sentiment: A detailed piece on Centene’s 2025 loss and the 2026 outlook raises concerns that recent losses and forward guidance could materially change investor expectations and valuation — this coverage likely pressures the stock. 2025 Loss / 2026 Outlook Article

Centene Profile

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.